{"transactions":[{"id":866725,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:33.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":548782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":548782,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":548782},"source":{"system":"sec-edgar","filing":"0001140361-26-007649","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007649/form4.xml","form_type":"4"}},{"id":1081378,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:55.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027405/form4.xml","form_type":"4"}},{"id":1081377,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:55.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":5.87,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-25-027405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027405/form4.xml","form_type":"4"}},{"id":2060307,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-06T21:59:10.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":385300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 385,300 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027."}],"balance_after":385300,"derivative":{"exercise_price":11.61,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":385300},"source":{"system":"sec-edgar","filing":"0001140361-23-000824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123000824/form4.xml","form_type":"4"}},{"id":2098171,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-02T21:47:14.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":219535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":6.57,"expiration_date":"2022-12-03","underlying":"Common Stock","underlying_shares":219535},"source":{"system":"sec-edgar","filing":"0001140361-22-044259","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122044259/form4.xml","form_type":"4"}},{"id":2098170,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Common Stock","published_at":"2022-12-02T21:47:14.000Z","date":"2022-12-02","kind":"tax_withholding","acquired":false,"shares":175184,"price":9.78,"value":1713299.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 2, 2022, Dr. Bedu-Addo made a net exercise of 219,535 stock options, resulting in his acquisition of 44,351 common shares of the Issuer."}],"balance_after":690866,"source":{"system":"sec-edgar","filing":"0001140361-22-044259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122044259/form4.xml","form_type":"4"}},{"id":2098169,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Common Stock","published_at":"2022-12-02T21:47:14.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":219535,"price":6.57,"value":1442344.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 2, 2022, Dr. Bedu-Addo made a net exercise of 219,535 stock options, resulting in his acquisition of 44,351 common shares of the Issuer."}],"balance_after":866050,"source":{"system":"sec-edgar","filing":"0001140361-22-044259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122044259/form4.xml","form_type":"4"}},{"id":2430414,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:05:37.000Z","date":"2022-01-19","kind":"grant","acquired":false,"shares":291500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 291,500 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026."}],"balance_after":291500,"derivative":{"exercise_price":6.28,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":291500},"source":{"system":"sec-edgar","filing":"0001140361-22-002188","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122002188/form4.xml","form_type":"4"}},{"id":2663667,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T23:26:07.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":53174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":6.57,"expiration_date":"2021-07-27","underlying":"Common Stock","underlying_shares":53174},"source":{"system":"sec-edgar","filing":"0001140361-21-021503","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021503/form4.xml","form_type":"4"}},{"id":2663666,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Common Stock","published_at":"2021-06-17T23:26:07.000Z","date":"2021-06-15","kind":"tax_withholding","acquired":false,"shares":27166,"price":12.86,"value":349354.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021."}],"balance_after":646515,"source":{"system":"sec-edgar","filing":"0001140361-21-021503","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021503/form4.xml","form_type":"4"}},{"id":2663665,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Common Stock","published_at":"2021-06-17T23:26:07.000Z","date":"2021-06-15","kind":"exercise","acquired":true,"shares":53174,"price":6.57,"value":349353.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021."}],"balance_after":673681,"source":{"system":"sec-edgar","filing":"0001140361-21-021503","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021503/form4.xml","form_type":"4"}},{"id":2951675,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T21:10:08.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":707800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 8, 2020, subject to stockholder approval of the Issuer's Second Amended and Restated 2014 Equity Incentive Plan under Nasdaq Marketplace Rule 5635(c). The option is not exercisable until stockholder approval has been obtained. Contingent upon stockholder approval, one-quarter of the shares subject to the option shall vest on December 8, 2021, and the remainder shall vest in equal monthly installments thereafter until fully vested on December 8, 2024. In the event stockholder approval is not obtained pursuant to the terms of grant, then the Reporting Person shall surrender the option to the Company for cancellation."}],"balance_after":707800,"derivative":{"exercise_price":2.43,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":707800},"source":{"system":"sec-edgar","filing":"0001140361-20-027860","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120027860/form4.xml","form_type":"4"}},{"id":3099728,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-25T22:24:38.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 125,000 shares of Common Stock, will become exercisable on June 23, 2021, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001140361-20-014759","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120014759/form4.xml","form_type":"4"}},{"id":3474703,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-07-01T20:33:19.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 100,000 shares of Common Stock, will become exercisable on June 28, 2020, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":5.99,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-19-023219","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760219023219/form4.xml","form_type":"4"}}]}